These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 191986)

  • 1. [Effect of izatizon and OL-56 on the reproductive and transformational properties of Marek's disease virus].
    Kudriavtsev FS; Solov'ev IuV; Korovin RN; Shurchilov AF
    Veterinariia; 1977; (2):45-6. PubMed ID: 191986
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of acyclovir on the replication of turkey herpesvirus and Marek's disease virus.
    Samorek-Salamonowicz E; Cakala A; Wijaszka T
    Res Vet Sci; 1987 May; 42(3):334-8. PubMed ID: 3039621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiviral isatin-3-thiocarbonylhydrazones and -isothiosemicarbazones and related compounds].
    Heinisch L; Tonew M
    Pharmazie; 1976; 31(12):840-5. PubMed ID: 1023259
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of certain mannich N-bases, derivatives of isatin beta-thiosemicarbazone, on the replication of vaccinia virus in in vitro studies.
    Borysiewicz J; Lucka-Sobstel B
    Acta Microbiol Pol; 1978; 27(2):111-21. PubMed ID: 80923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory activity of cytosine arabinoside on Marek's disease virus.
    Benda V
    Folia Biol (Praha); 1982; 28(5):311-6. PubMed ID: 6293895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fluorescent antibody method in the study of an antiviral agent: 5-sulfamido--isatin-thiosemicarbazone].
    Alexandrescu M; Handrache L; Murgescu C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1975; 20(2):113-8. PubMed ID: 128095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunogenic activity of vaccines against Marek's disease].
    Persov AS; Korovin RN; Lokh VA; Aĭrapetov RG; Matiushkov VS
    Veterinariia; 1978 Jul; (7):41-2. PubMed ID: 210559
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiviral thiosemicarbazone and related compounds. III. Quantitative relationships between structure and antiviral activity of isantin-beta-isothio-semicarbazone against mengo virus].
    Franke R; Labes D; Tonew M; Zschiesche W; Heinisch L
    Acta Biol Med Ger; 1975; 34(3):491-9. PubMed ID: 171890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AUS in the prevention of Marek's disease.
    Chang TS
    Avian Dis; 1984; 28(1):154-9. PubMed ID: 6326736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-specific antiviral activity of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine (FIAC) against Marek's disease herpesvirus and turkey herpesvirus.
    Schat KA; Schinazi RF; Calnek BW
    Antiviral Res; 1984 Oct; 4(5):259-70. PubMed ID: 6097179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of isatin beta-thiosemicarbazone derivatives on vaccinia virus multiplication in L-132 cell line (human embryonic lung).
    Zgòrniak-Nowosielska I; Marciszewska M; Pastuszak J; Lucka-Sobstel B
    Acta Microbiol Pol A; 1973; 5(3):199-204. PubMed ID: 4769558
    [No Abstract]   [Full Text] [Related]  

  • 12. Notes on the mechanism of postvaccination immunity in Marek's disease.
    Yakovleva LS; Mazurenko NP
    Neoplasma; 1977; 24(4):387-94. PubMed ID: 198688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of phosphonoacetate on Marek's disease virus replication.
    Lee LF; Nazerian K; Leinbach SS; Reno JM; Boezi JA
    J Natl Cancer Inst; 1976 Apr; 56(4):823-7. PubMed ID: 176410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pathogenesis studies with oncogenic and nononcogenic Marek's disease viruses and turkey herpesvirus.
    Calnek BW; Carlisle JC; Fabricant J; Murthy KK; Schat KA
    Am J Vet Res; 1979 Apr; 40(4):541-8. PubMed ID: 229747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of vaccinia, sindbis and para-influenza virus replication by isatin beta-thiosemicarbazone derivative and methisazone in vitro and in vivo].
    Poteć Z; Zgórniak-Nowosielska I
    Folia Med Cracov; 1979; 21(1):3-13. PubMed ID: 232050
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of a bivalent vaccine against Marek's disease.
    Pruthi AK; Gupta RK; Sadana JR
    Res Vet Sci; 1987 Mar; 42(2):145-9. PubMed ID: 3035660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of virus-neutralizing antibodies in Marek's disease of chickens. 1. Immunity control following Marek's vaccination with turkey Herpes Virus (THV)].
    von dem Hagen D; Löliger HC
    Dtsch Tierarztl Wochenschr; 1978 Jun; 85(6):220-2. PubMed ID: 207505
    [No Abstract]   [Full Text] [Related]  

  • 18. Marek's disease in chickens: correlation of Marek's disease with nuclear-inclusion formation in feather-follicle epithelium.
    Moriguchi R; Izawa H
    Avian Dis; 1979; 23(3):547-54. PubMed ID: 230801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial optimization of isatin-beta-thiosemicarbazones as anti-poxvirus agents.
    Pirrung MC; Pansare SV; Sarma KD; Keith KA; Kern ER
    J Med Chem; 2005 Apr; 48(8):3045-50. PubMed ID: 15828843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the role of macrophages in Marek's disease of the chicken.
    Powell PC; Hartley KJ; Mustill BM; Rennie M
    J Reticuloendothel Soc; 1983 Oct; 34(4):289-97. PubMed ID: 6312038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.